You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Sports Medicines Industry Research Report, Growth Trends and Competitive Analysis 2021-2027

The global Sports Medicines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
In terms of production side, this report researches the Sports Medicines production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Sports Medicines by regions (countries) and by Application.
The global Sports Medicines market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Sports Medicines market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Sports Medicines markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Sports Medicines market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Sports Medicines market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Sports Medicines market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Sports Medicines market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Sports Medicines market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Sports Medicines market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Sports Medicines market by each application segment for the same period.
This report includes the following manufacturers:
Anika Therapeutics
Arthrex
Breg
BSN Medical
ConMed
Cramer Sports Medicine
DePuy Synthes
DJO
MedShape
Integra LifeSciences
KARL STORZ Endoskope
Medtronic
Mueller Sports Medicine
RTI Surgical
Sanofi
Smith & Nephew
Zimmer Biomet
Stryker
Wright Medical
Market Segment by Type
External Application
Internal Medicine
Market Segment by Application
Hospital
Clinic
Sport Clubs
Other
Research Methodology
To compile the detailed study of the global Sports Medicines market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Sports Medicines market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Sports Medicines market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Sports Medicines Market Size Growth Rate by Type
1.2.2 External Application
1.2.3 Internal Medicine
1.3 Market Segment by Application
1.3.1 Global Sports Medicines Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Sport Clubs
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Market Perspective
2.1 Global Sports Medicines Market Size (2016-2027)
2.1.1 Global Sports Medicines Revenue (2016-2027)
2.1.2 Global Sports Medicines Sales (2016-2027)
2.2 Global Sports Medicines Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Sports Medicines Sales by Regions (2016-2021)
2.2.2 Global Sports Medicines Revenue by Regions (2016-2021)
2.3 Global Sports Medicines Market Size Forecast by Region
2.3.1 Global Sports Medicines Sales Forecast by Region (2022-2027)
2.3.2 Global Sports Medicines Revenue Forecast by Region (2022-2027)
2.4 Global Top Sports Medicines Regions (Countries) Ranking by Market Size
2.5 Sports Medicines Industry Trends
2.5.1 Sports Medicines Market Trends
2.5.2 Sports Medicines Market Drivers
2.5.3 Sports Medicines Market Challenges
2.5.4 Sports Medicines Market Restraints

3 Competitive Landscape by Manufacturers
3.1 Global Top Sports Medicines Manufacturers by Sales (2016-2021)
3.1.1 Global Sports Medicines Sales by Manufacturers (2016-2021)
3.1.2 Global Sports Medicines Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Sports Medicines Sales in 2020
3.2 Global Top Manufacturers Sports Medicines by Revenue
3.2.1 Global Sports Medicines Revenue by Manufacturers (2016-2021)
3.2.2 Top Sports Medicines Manufacturers Covered: Ranking by Revenue
3.2.3 Global Sports Medicines Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Sports Medicines Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sports Medicines as of 2020)
3.4 Global Sports Medicines Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Sports Medicines Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Sports Medicines Market
3.7 Key Manufacturers Sports Medicines Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Global Sports Medicines Market Size by Type
4.1 Global Sports Medicines Historic Market Review by Type (2016-2021)
4.1.1 Global Sports Medicines Sales Market Share by Type (2016-2021)
4.1.2 Global Sports Medicines Revenue Market Share by Type (2016-2021)
4.1.3 Sports Medicines Price by Type (2016-2021)
4.2 Global Sports Medicines Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Sports Medicines Sales Forecast by Type (2022-2027)
4.2.2 Global Sports Medicines Revenue Forecast by Type (2022-2027)
4.2.3 Sports Medicines Price Forecast by Type (2022-2027)

5 Global Sports Medicines Market Size by Application
5.1 Global Sports Medicines Historic Market Review by Application (2016-2021)
5.1.1 Global Sports Medicines Sales Market Share by Application (2016-2021)
5.1.2 Global Sports Medicines Revenue Market Share by Application (2016-2021)
5.1.3 Sports Medicines Price by Application (2016-2021)
5.2 Global Sports Medicines Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Sports Medicines Sales Forecast by Application (2022-2027)
5.2.2 Global Sports Medicines Revenue Forecast by Application (2022-2027)
5.2.3 Sports Medicines Price Forecast by Application (2022-2027)

6 North America
6.1 North America Sports Medicines Sales Breakdown by Company
6.1.1 North America Sports Medicines Sales by Company (2016-2027)
6.1.2 North America Sports Medicines Revenue by Company (2016-2027)
6.2 North America Sports Medicines Market Size by Type (2016-2027)
6.2.1 North America Sports Medicines Sales by Type (2016-2027)
6.2.2 North America Sports Medicines Revenue by Type (2016-2027)
6.3 North America Sports Medicines Market Size by Application (2016-2027)
6.3.1 North America Sports Medicines Sales by Application (2016-2027)
6.3.2 North America Sports Medicines Revenue by Application (2016-2027)
6.4 North America Sports Medicines Market Size by Country
6.4.1 North America Sports Medicines Sales by Country (2016-2027)
6.4.2 North America Sports Medicines Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Sports Medicines Sales Breakdown by Company
7.1.1 Europe Sports Medicines Sales by Company (2016-2027)
7.1.2 Europe Sports Medicines Revenue by Company (2016-2027)
7.2 Europe Sports Medicines Market Size by Type (2016-2027)
7.2.1 Europe Sports Medicines Sales by Type (2016-2027)
7.2.2 Europe Sports Medicines Revenue by Type (2016-2027)
7.3 Europe Sports Medicines Market Size by Application (2016-2027)
7.3.1 Europe Sports Medicines Sales by Application (2016-2027)
7.3.2 Europe Sports Medicines Revenue by Application (2016-2027)
7.4 Europe Sports Medicines Market Size by Country
7.4.1 Europe Sports Medicines Sales by Country (2016-2027)
7.4.2 Europe Sports Medicines Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Sports Medicines Sales Breakdown by Company
8.1.1 Asia Pacific Sports Medicines Sales by Company (2016-2027)
8.1.2 Asia Pacific Sports Medicines Revenue by Company (2016-2027)
8.2 Asia Pacific Sports Medicines Market Size by Type (2016-2027)
8.2.1 Asia Pacific Sports Medicines Sales by Type (2016-2027)
8.2.2 Asia Pacific Sports Medicines Revenue by Type (2016-2027)
8.3 Asia Pacific Sports Medicines Market Size by Application (2016-2027)
8.3.1 Asia Pacific Sports Medicines Sales by Application (2016-2027)
8.3.2 Asia Pacific Sports Medicines Revenue by Application (2016-2027)
8.4 Asia Pacific Sports Medicines Market Size by Regions
8.4.1 Asia Pacific Sports Medicines Sales by Regions
8.4.2 Asia Pacific Sports Medicines Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Sports Medicines Sales Breakdown by Company
9.1.1 Latin America Sports Medicines Sales by Company (2016-2027)
9.1.2 Latin America Sports Medicines Revenue by Company (2016-2027)
9.2 Latin America Sports Medicines Market Size by Type (2016-2027)
9.2.1 Latin America Sports Medicines Sales by Type (2016-2027)
9.2.2 Latin America Sports Medicines Revenue by Type (2016-2027)
9.3 Latin America Sports Medicines Market Size by Application (2016-2027)
9.3.1 Latin America Sports Medicines Sales by Application (2016-2027)
9.3.2 Latin America Sports Medicines Revenue by Application (2016-2027)
9.4 Latin America Sports Medicines Market Size by Country
9.4.1 Latin America Sports Medicines Sales by Country (2016-2027)
9.4.2 Latin America Sports Medicines Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Sports Medicines Sales Breakdown by Company
10.1.1 Middle East and Africa Sports Medicines Sales by Company (2016-2027)
10.1.2 Middle East and Africa Sports Medicines Revenue by Company (2016-2027)
10.2 Middle East and Africa Sports Medicines Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Sports Medicines Sales by Type (2016-2027)
10.2.2 Middle East and Africa Sports Medicines Revenue by Type (2016-2027)
10.3 Middle East and Africa Sports Medicines Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Sports Medicines Sales by Application (2016-2027)
10.3.2 Middle East and Africa Sports Medicines Revenue by Application (2016-2027)
10.4 Middle East and Africa Sports Medicines Market Size by Country
10.4.1 Middle East and Africa Sports Medicines Sales by Country (2016-2027)
10.4.2 Middle East and Africa Sports Medicines Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Company Profiles
11.1 Anika Therapeutics
11.1.1 Anika Therapeutics Corporation Information
11.1.2 Anika Therapeutics Overview
11.1.3 Anika Therapeutics Sports Medicines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Anika Therapeutics Sports Medicines Products and Services
11.1.5 Anika Therapeutics Sports Medicines SWOT Analysis
11.1.6 Anika Therapeutics Recent Developments
11.2 Arthrex
11.2.1 Arthrex Corporation Information
11.2.2 Arthrex Overview
11.2.3 Arthrex Sports Medicines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 Arthrex Sports Medicines Products and Services
11.2.5 Arthrex Sports Medicines SWOT Analysis
11.2.6 Arthrex Recent Developments
11.3 Breg
11.3.1 Breg Corporation Information
11.3.2 Breg Overview
11.3.3 Breg Sports Medicines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Breg Sports Medicines Products and Services
11.3.5 Breg Sports Medicines SWOT Analysis
11.3.6 Breg Recent Developments
11.4 BSN Medical
11.4.1 BSN Medical Corporation Information
11.4.2 BSN Medical Overview
11.4.3 BSN Medical Sports Medicines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 BSN Medical Sports Medicines Products and Services
11.4.5 BSN Medical Sports Medicines SWOT Analysis
11.4.6 BSN Medical Recent Developments
11.5 ConMed
11.5.1 ConMed Corporation Information
11.5.2 ConMed Overview
11.5.3 ConMed Sports Medicines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 ConMed Sports Medicines Products and Services
11.5.5 ConMed Sports Medicines SWOT Analysis
11.5.6 ConMed Recent Developments
11.6 Cramer Sports Medicine
11.6.1 Cramer Sports Medicine Corporation Information
11.6.2 Cramer Sports Medicine Overview
11.6.3 Cramer Sports Medicine Sports Medicines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 Cramer Sports Medicine Sports Medicines Products and Services
11.6.5 Cramer Sports Medicine Sports Medicines SWOT Analysis
11.6.6 Cramer Sports Medicine Recent Developments
11.7 DePuy Synthes
11.7.1 DePuy Synthes Corporation Information
11.7.2 DePuy Synthes Overview
11.7.3 DePuy Synthes Sports Medicines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 DePuy Synthes Sports Medicines Products and Services
11.7.5 DePuy Synthes Sports Medicines SWOT Analysis
11.7.6 DePuy Synthes Recent Developments
11.8 DJO
11.8.1 DJO Corporation Information
11.8.2 DJO Overview
11.8.3 DJO Sports Medicines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 DJO Sports Medicines Products and Services
11.8.5 DJO Sports Medicines SWOT Analysis
11.8.6 DJO Recent Developments
11.9 MedShape
11.9.1 MedShape Corporation Information
11.9.2 MedShape Overview
11.9.3 MedShape Sports Medicines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.9.4 MedShape Sports Medicines Products and Services
11.9.5 MedShape Sports Medicines SWOT Analysis
11.9.6 MedShape Recent Developments
11.10 Integra LifeSciences
11.10.1 Integra LifeSciences Corporation Information
11.10.2 Integra LifeSciences Overview
11.10.3 Integra LifeSciences Sports Medicines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.10.4 Integra LifeSciences Sports Medicines Products and Services
11.10.5 Integra LifeSciences Sports Medicines SWOT Analysis
11.10.6 Integra LifeSciences Recent Developments
11.11 KARL STORZ Endoskope
11.11.1 KARL STORZ Endoskope Corporation Information
11.11.2 KARL STORZ Endoskope Overview
11.11.3 KARL STORZ Endoskope Sports Medicines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.11.4 KARL STORZ Endoskope Sports Medicines Products and Services
11.11.5 KARL STORZ Endoskope Recent Developments
11.12 Medtronic
11.12.1 Medtronic Corporation Information
11.12.2 Medtronic Overview
11.12.3 Medtronic Sports Medicines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.12.4 Medtronic Sports Medicines Products and Services
11.12.5 Medtronic Recent Developments
11.13 Mueller Sports Medicine
11.13.1 Mueller Sports Medicine Corporation Information
11.13.2 Mueller Sports Medicine Overview
11.13.3 Mueller Sports Medicine Sports Medicines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.13.4 Mueller Sports Medicine Sports Medicines Products and Services
11.13.5 Mueller Sports Medicine Recent Developments
11.14 RTI Surgical
11.14.1 RTI Surgical Corporation Information
11.14.2 RTI Surgical Overview
11.14.3 RTI Surgical Sports Medicines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.14.4 RTI Surgical Sports Medicines Products and Services
11.14.5 RTI Surgical Recent Developments
11.15 Sanofi
11.15.1 Sanofi Corporation Information
11.15.2 Sanofi Overview
11.15.3 Sanofi Sports Medicines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.15.4 Sanofi Sports Medicines Products and Services
11.15.5 Sanofi Recent Developments
11.16 Smith & Nephew
11.16.1 Smith & Nephew Corporation Information
11.16.2 Smith & Nephew Overview
11.16.3 Smith & Nephew Sports Medicines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.16.4 Smith & Nephew Sports Medicines Products and Services
11.16.5 Smith & Nephew Recent Developments
11.17 Zimmer Biomet
11.17.1 Zimmer Biomet Corporation Information
11.17.2 Zimmer Biomet Overview
11.17.3 Zimmer Biomet Sports Medicines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.17.4 Zimmer Biomet Sports Medicines Products and Services
11.17.5 Zimmer Biomet Recent Developments
11.18 Stryker
11.18.1 Stryker Corporation Information
11.18.2 Stryker Overview
11.18.3 Stryker Sports Medicines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.18.4 Stryker Sports Medicines Products and Services
11.18.5 Stryker Recent Developments
11.19 Wright Medical
11.19.1 Wright Medical Corporation Information
11.19.2 Wright Medical Overview
11.19.3 Wright Medical Sports Medicines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.19.4 Wright Medical Sports Medicines Products and Services
11.19.5 Wright Medical Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Sports Medicines Value Chain Analysis
12.2 Sports Medicines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Sports Medicines Production Mode & Process
12.4 Sports Medicines Sales and Marketing
12.4.1 Sports Medicines Sales Channels
12.4.2 Sports Medicines Distributors
12.5 Sports Medicines Customers
13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
  • FORMAT: PDF
  • PUBLISHED DATE: Mar, 2021
  • NO OF PAGES: 102